Enzon Pharmaceuticals Inc. Message Board

moses.genius moses.genius • Jan 15, 2013 8:33 AM Flag

1 users liked this posts users disliked this posts 0

Reply

Lazard Capital just started Nector as a Buy
Lazard Capital, same company handling Enzon sale, is recommending Nector as a BUY today.

Nector is the sister company to Enzon. Yet Nector has hasn't the book value ,or the cash that Enzon

has ,and yet trading near $9 a share with twice the number of shares outstanding. What does this tell

you????

Sentiment: Hold
Sort: Newest | Oldest | Most Replied Expand all replies
- moses.genius moses.genius • Jan 15, 2013 8:40 AM Flag
  
  2 users liked this posts users disliked this posts 0
  
  Reply
  Actually has close to three times the number of shares outstanding and a book value of 1/4 of Enzon's with less total net capital in cash.
  
  Sentiment: Hold
  - 1 Reply to moses.genius
  - chimakot chimakot • Jan 15, 2013 12:22 PM Flag
    
    1 users liked this posts users disliked this posts 0
    
    Reply
    
    It tells me some biotech will be getting a great deal acquiring ENZN. I'm now thinking we get $10+ for this cash cow.
    
    Sentiment: Strong Buy

Back To Board

Previous topic Next topic

ENZN

1.700.00(+0.00%)Jun 19 4:00 PMEDT